UT Southwestern Medical
Center’s cancer physicians and scientists are continuously pursuing new
diagnostic tools and treatments in studies ranging from small preliminary
investigations to large multicenter trials. These efforts are important to
extend survival and improve the prognosis for people with pancreatic cancer,
which is among the most aggressive and deadly malignancies.
Current research
includes studies that seek to:
- Develop new chemotherapy agents that
precisely target cancer cells or the cellular machinery that allows them
to grow and spread
- Detect and diagnose pancreatic cancer
earlier
- Test and evaluate surgical techniques
that could ease recovery and improve outcomes
- Optimize the effectiveness of
radiation therapy
As one of the
nation’s leading academic medical centers, UT Southwestern offers a broad array
of clinical trials aimed at improving the outcomes for patients at various
stages of pancreatic cancer.
Patients who qualify
and choose to participate in one of our clinical trials might receive promising
new therapies months or even years before they are available to the public,
providing hope for better outcomes and improving care for all patients.
Patients interested
in being considered for a pancreatic cancer clinical trial should speak with
their UT Southwestern physician or the contact associated with a specific
trial.
Find current pancreatic cancer clinical trials.
